Eversept Partners, LP Repligen Corp Transaction History

Eversept Partners, LP

$1.33 Billion
Q1 2024

A detailed history of Eversept Partners, LP transactions in Repligen Corp stock. As of the latest transaction made, Eversept Partners, LP holds 8,237 shares of RGEN stock, worth $989,593. This represents 0.11% of its overall portfolio holdings.

Number of Shares

8,237

Previous 9,984 17.5%

Holding current value

$989,593

Previous $1.8 Million 15.65%

% of portfolio

0.11%

Previous 0.18%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $298,352 - $364,109	-1,747 Reduced 17.5%	8,237 $1.51 Million
Q4 2023 Feb 14, 2024	SELL	$114.17 - $185.35 $704,314 - $1.14 Million	-6,169 Reduced 38.19%	9,984 $1.8 Million
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $6.93 Million - $8.81 Million	-49,914 Reduced 75.55%	16,153 $2.57 Million
Q2 2023 Nov 08, 2023	BUY	$138.42 - $180.31 $8.36 Million - $10.9 Million	60,411 Added 1068.09%	66,067 $9.35 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $8.36 Million - $10.9 Million	60,411 Added 1068.09%	66,067 $9.35 Million

Q1 2023 Nov 08, 2023	SELL	$154.26 - $198.1 $7.92 Million - $10.2 Million	-51,348 Reduced 90.08%	5,656 $952,000
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $7.92 Million - $10.2 Million	-51,348 Reduced 90.08%	5,656 $952,000
Q4 2022 Nov 08, 2023	BUY	$162.42 - $220.56 $8.67 Million - $11.8 Million	53,363 Added 1465.61%	57,004 $9.65 Million
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $8.67 Million - $11.8 Million	53,363 Added 1465.61%	57,004 $9.65 Million
Q3 2022 Nov 08, 2023	SELL	$160.42 - $256.21 $329,181 - $525,742	-2,052 Reduced 36.04%	3,641 $681,000
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $329,181 - $525,742	-2,052 Reduced 36.04%	3,641 $681,000
Q2 2022 Nov 08, 2023	SELL	$140.68 - $188.02 $4.34 Million - $5.8 Million	-30,828 Reduced 84.41%	5,693 $924,000
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $4.34 Million - $5.8 Million	-30,828 Reduced 84.41%	5,693 $925,000
Q1 2022 Nov 08, 2023	SELL	$161.19 - $257.96 $4.76 Million - $7.62 Million	-29,546 Reduced 44.72%	36,521 $6.87 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $5.15 Million - $8.24 Million	31,937 Added 696.71%	36,521 $6.87 Million
Q4 2021 Nov 08, 2023	BUY	$247.59 - $304.47 $45,061 - $55,413	182 Added 4.13%	4,584 $1.21 Million
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $45,061 - $55,413	182 Added 4.13%	4,584 $1.21 Million
Q3 2021 Nov 08, 2023	BUY	$194.77 - $324.21 $138,286 - $230,189	710 Added 19.23%	4,402 $1.27 Million
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $138,286 - $230,189	710 Added 19.23%	4,402 $1.27 Million
Q2 2021 Nov 08, 2023	BUY	$165.87 - $220.95 $375,529 - $500,230	2,264 Added 158.54%	3,692 $736,000
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $375,529 - $500,230	2,264 Added 158.54%	3,692 $737,000
Q1 2021 Nov 08, 2023	SELL	$180.37 - $226.26 $11.7 Million - $14.6 Million	-64,639 Reduced 97.84%	1,428 $277,000
Q1 2021 May 13, 2021	BUY	$180.37 - $226.26 $257,568 - $323,099	1,428 New	1,428 $278,000

Others Institutions Holding RGEN

# of Institutions

522

Shares Held

53.2M

Call Options Held

1.05M

Put Options Held

228K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.67B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Account

Eversept Partners, LP Repligen Corp Transaction History